Dentsply Sirona
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XRAY and other ETFs, options, and stocks.About XRAY
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare.
CEODaniel T. Scavilla
CEODaniel T. Scavilla
Employees14,000
Employees14,000
HeadquartersCharlotte, North Carolina
HeadquartersCharlotte, North Carolina
Founded1899
Founded1899
Employees14,000
Employees14,000
XRAY Key Statistics
Market cap2.68B
Market cap2.68B
Price-Earnings ratio-2.87
Price-Earnings ratio-2.87
Dividend yield4.70%
Dividend yield4.70%
Average volume2.82M
Average volume2.82M
High today$14.04
High today$14.04
Low today$13.41
Low today$13.41
Open price$13.61
Open price$13.61
Volume2.82M
Volume2.82M
52 Week high$27.48
52 Week high$27.48
52 Week low$12.16
52 Week low$12.16
XRAY News
Simply Wall St 3d
Will Holding Wellspect Help DENTSPLY SIRONA Sharpen Its Long-Term Strategy?DENTSPLY SIRONA recently announced it has completed its review of strategic alternatives for Wellspect Healthcare, ultimately deciding to retain the subsidiary...
Simply Wall St 5d
DENTSPLY SIRONA Retains Wellspect Business Citing Greater Value for Shareholdersrecently decided to retain its subsidiary Wellspect Healthcare, believing in its potential for greater value generation. This, alongside the decision to enhance...
TipRanks 7d
Hold Rating for DENTSPLY SIRONA Amid Strategic Retention of Wellspect and Focus on Core Dental Business RevitalizationLeerink Partners analyst Michael Cherny maintained a Hold rating on DENTSPLY SIRONA on September 9 and set a price target of $14.50. Elevate Your Investing Stra...
Analyst ratings
78%
of 18 ratingsBuy
22.2%
Hold
77.8%
Sell
0%
People also own
Based on the portfolios of people who own XRAY. This list is generated using Robinhood data, and it’s not a recommendation.